Multiple desmoid tumors in a patient with familial adenomatous polyposis caused by the novel W421X mutation.

Familial adenomatous polyposis (FAP) is a rare syndrome characterized by the presence of hundreds to thousands of colorectal adenomas and is responsible for less than 1% of all colorectal cancers. The syndrome is also characterized by extra-colorectal features including amongst others upper gastrointestinal tract polyps and desmoid tumors. The syndrome is inherited by an autosomal dominant gene, the adenomatous polyposis coli (APC) gene. We present the physical history, clinical presentation, diagnosis and treatment of a patient with a novel germline APC mutation, the W421X mutation, which resulted in FAP presenting with about a hundred colorectal polyps, gastric hyperplastic polyps and multiple aggressive intra-abdominal and extra-abdominal desmoid tumors.

[1]  J. Lefèvre,et al.  Desmoid tumour in familial adenomatous polyposis patients: responses to treatments , 2015, Familial Cancer.

[2]  J. Blay,et al.  Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  R. García-Lozano,et al.  Andalusian Registry for familial adenomatous polyposis. Analysis of patients included. , 2010, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[4]  A. J. Molina,et al.  Andalusian Registry for Familial Adenomatous Polyposis: Analysis of patients included , 2010 .

[5]  Dafydd G. Thomas,et al.  Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial , 2010, Clinical Cancer Research.

[6]  M. Urioste,et al.  Surgical management of hereditary colorectal cancer: surgery based on molecular analysis and family history. , 2009, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[7]  J. Manivel,et al.  Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors , 2009, Cancer Chemotherapy and Pharmacology.

[8]  M. Muñoz-Navas,et al.  Recognition and management of hereditary colorectal cancer syndromes. , 2009, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[9]  J. Jass Colorectal polyposes: from phenotype to diagnosis. , 2008, Pathology, research and practice.

[10]  Á. Pizarro,et al.  Clinical and ethical implications of genetic counselling in familial adenomatous polyposis. , 2005, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[11]  L. Lipton,et al.  The genetics of FAP and FAP-like syndromes , 2005, Familial Cancer.

[12]  S. Clark,et al.  Current ideas in desmoid tumours , 2005, Familial Cancer.

[13]  S. Bülow,et al.  Desmoid tumour in familial adenomatous polyposis. A review of literature , 2004, Familial Cancer.

[14]  H. Redmond,et al.  Desmoid tumours. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  H. Järvinen,et al.  Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment , 1996, International Journal of Colorectal Disease.